Skip to main content
. 2014 May 15;171(11):2767–2777. doi: 10.1111/bph.12597

Figure 7.

Figure 7

The effect of the CB1 receptor antagonist SR141716 (3 μM) on inhibition of EFS-induced cholinergic contraction in human bronchi by Δ9-THC, WIN55,212-2 and CP55,940. Data are shown as mean ± SEM value percentage inhibition of cholinergic contraction obtained with bronchi from 10 different patients.